[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Cancer Market Research Reports & Industry Analysis

Cancer is a package of diseases marked by uncurbed growth and proliferation of anomalous cells. The illness is generally assumed to be the fruit of the impact of assorted outside factors and inner forces, such as tobacco smoking, radiation exposure, chemicals’ influences, infectious agents, inherited gene mutations, hormonal disorders, immune system conditions and mutations of other origins, among others.

Thus far, the Cancer Market has already seen noticeable progress in early-stage tumor detection and cure globally. The market for Cancer diagnostics is close to explosive growth, promising to reach approximately EUR 4 billion in value by end-2015. Further, technology discoveries will continue to afford many chances of demystifying the genetic components of the sickness, identifying specific tumor types, and observing biological reaction to cancer treatments. However, the bulk of presently available therapies do not fully protect against some unwelcomed side-effects.

The research reports in this Catalogue present global, regional and nation-level analyses of the Cancer Market development trends over different time spans. The research reports identify major bizopps emerging in the Cancer Market; examine versatile Cancer diagnostic test technologies along with their applications, besides looking into other Cancer Market issues. The research reports also profile the top players and would-be entrants, as well as offer test volume and sales projections.

Publications found: 1,863
Sort by:

Competitor Analysis: Bispecific Antibodies for Cancer, Inflammatory & Other Diseases

US$ 560.00

Competitor Analysis: Bispecific Antibodies for Cancer, Inflammatory Other Diseases This Competitive Intelligence report about Bispecific Antibodies for Cancer, Inflammatory Other Diseases evaluates the competitive ... as: T-Cell or NK cell redirecting bispecific cancer antibodies Bispecific immuno-oncology antibodies Bispecific tumor antigens targeted cancer antibodies Bispecific antibodies for inflammatory autoimmune diseases Bispecific antibodies for cardiometabolic, infectious, neurologic ...

June 2016 180 pages

Global Personalized Cancer Therapy Industry 2016 Market Research Report

US$ 2,850.00

2016 Global Personalized Cancer Therapy Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Personalized Cancer Therapy industry, focusing on the ... with: 1.) basic information; 2.) the Asia Personalized Cancer Therapy industry; 3.) the North American Personalized Cancer Therapy industry; 4.) the European Personalized Cancer Therapy industry; 5.) market entry and investment feasibility ...

May 2016 156 pages

Epiomic Epidemiology Series: Brain & CNS Cancer Forecast in 19 Major Markets 2016-2026

US$ 6,382.00

... co-morbidities for Brain & CNS Cancer include: Genetic susceptibility Family history of brain & CNS ... and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate ... information from patient registries, clinical trials and epidemiology studies. All of the sources used to ...

April 2016 66 pages

Global Gastric Cancer Market Report: 2016 Edition

US$ 800.00

... include surgery, chemotherapy, radiotherapy and targeted therapy. Global gastric cancer market is conspicuous by poor prognosis, because of the indolent ... cancer drugs. The report provides an overview of the entire market through global and regional analysis. Prevalence and market value of gastric cancer ...

April 2016 52 pages

Global Colon Cancer Treatment Drugs Industry 2016 Market Research Report

US$ 2,850.00

2016 Global Colon Cancer Treatment Drugs Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Colon Cancer Treatment Drugs industry, focusing on the ... with: 1.) basic information; 2.) the Asia Colon Cancer Treatment Drugs industry; 3.) the North American Colon Cancer Treatment Drugs industry; 4.) the European Colon Cancer Treatment Drugs industry; 5.) market entry and investment feasibility ...

April 2016 158 pages

Global Ovarian Cancer Treatment Drugs Industry 2016 Market Research Report

US$ 2,850.00

2016 Global Ovarian Cancer Treatment Drugs Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Ovarian Cancer Treatment Drugs industry, focusing on the ... with: 1.) basic information; 2.) the Asia Ovarian Cancer Treatment Drugs industry; 3.) the North American Ovarian Cancer Treatment Drugs industry; 4.) the European Ovarian Cancer Treatment Drugs industry; 5.) market entry and investment feasibility ...

April 2016 158 pages

Global Radiology Oncology Surgical Robots Industry 2016 Market Research Report

US$ 2,850.00

2016 Global Radiology Oncology Surgical Robots Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Radiology Oncology Surgical Robots industry, focusing on the ... with: 1.) basic information; 2.) the Asia Radiology Oncology Surgical Robots industry; 3.) the North American Radiology Oncology Surgical Robots industry; 4.) the European Radiology Oncology Surgical Robots industry; 5.) market entry and investment feasibility ...

April 2016 158 pages

Global Cancer Stem Cell Therapy Market Outlook 2020

US$ 2,400.00

... Stem Cells Stem Cell Transplants Classification Cancer Stem Cell Therapy Mechanism of Action Global Cancer Stem Cell Market Analysis Global Cancer Stem Cell Clinical Pipeline by Company & Phase Global Cancer Stem Cell Clinical Pipeline: 32 Therapies Global Cancer Stem Cell Market ...

April 2016 132 pages

Global Circulating Tumor Cells (CTCs) Detector Industry 2016 Market Research Report

US$ 2,850.00

2016 Global Circulating Tumor Cells (CTCs) Detector Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Circulating Tumor Cells (CTCs) Detector industry ... : 1.) basic information; 2.) the Asia Circulating Tumor Cells (CTCs) Detector industry; 3.) the North American Circulating Tumor Cells (CTCs) Detector industry; 4.) the European Circulating Tumor Cells (CTCs) Detector industry; 5.) market entry and ...

March 2016 156 pages

2016-2020 Cancer Diagnostics: A Market on the Verge of Explosion-Technological Breakthroughs, Emerging Tests, Market Forecasts, Competitive Intelligence

US$ 19,600.00

... report is a study of the major business opportunities emerging in the global cancer diagnostics market during the next five years. The report examines trends ... applications of new diagnostic technologies; forecasts sales of major tumor markers by country and market segment; profiles leading players and potential market entrants; and ...

March 2016 1200 pages

Global Oncology Ablation Market Outlook: 2015-2020 (2nd Edition)

US$ 4,175.00

... titled “Global Oncology Ablation Market Outlook: 2015-2020” provides in-depth analysis of oncology ablation market in four major geographies. The report also emphasizes on the current trends in oncology ablation, market size, market share ...

March 2016 172 pages

Global Dendritic Cell Cancer Vaccine Market Outlook 2020

US$ 1,800.00

... Dendritic Cells New Vaccine Strategies That Exploit Dendritic Cells Biochemistry Dendritic Cell Cancer Vaccine Market & Clinical Insight Comparative Insight of Dendritic Cell Vaccines & Other Class of Vaccines Dendritic Cell Cancer Vaccine Pipeline by Country, Company, Indication & Phase Dendritic Cell Cancer ...

March 2016 213 pages

Epiomic Epidemiology Series: Stomach Cancer Forecast in 17 Major Markets 2016-2026

US$ 6,382.00

... Stomach Cancer include: History of stomach polyps or stomach lymphoma Family history of stomach cancer Family history of hereditary non-polyposis Colorectal cancer ... sourced from the proprietary Epiomic patient segmentation database. To ... patient registries, clinical trials and epidemiology studies. All of the ...

February 2016 66 pages

Breast Cancer: Update Bulletin [March 2016]

US$ 995.00

... with nab-paclitaxel for patients with metastatic triple- negative breast cancer (mTNBC); the US Food and Drug Administration (FDA) awarding ... of this expanded indication have on prescriptions of Ibrance and on those of Afinitor? Update Bulletins include expert insight and analysis based on FirstWord analyst re- ...

February 2016

Next generation cancer diagnostics - Global Market Outlook (2015-2022)

US$ 4,150.00

... . Growing incidence of oncology diseases is expected to boost the demand for next generation cancer diagnostic tests market. However, lack of sufficient reimbursement policies for novel ... the global next generation cancer diagnostics market growth over the forecast period. The largest segment of the global market for next generation cancer diagnostics is Blood-born cancers. Asia ...

February 2016 129 pages

Generic Oncology Drug Market - Industry Trends, Manufacturing Process, Plant Setup, Machinery, Raw Materials, Cost and Revenue

US$ 1,499.00

IMARC’s latest study “Generic Oncology Drug Market - Industry Trends, Manufacturing Process, Plant Setup, Machinery, Raw Materials, ... of the generic oncology market and who are the key players? What are the key success factors for generic oncology drug manufacturers? How are generic oncology drugs manufactured ...

February 2016 40 pages

A 33-Country Survey of the Tumor Marker Diagnostics Market: Sales Forecasts, Supplier Shares-Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains-Competitive Strategies, Emerging Opportunities

US$ 46,880.00

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives ... and market shares of major cancer diagnostic product suppliers in major countries by individual test. Five-year test volume and sales forecasts ...

February 2016 1300 pages

A 28-Country Survey of the European Tumor Marker Diagnostics Market: Sales Forecasts, Supplier Shares-Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains-Competitive Strategies, Emerging Opportunities

US$ 34,800.00

This new 28-country survey from VPGMarketResearch.com contains over 925 pages and 366 tables. The survey is designed to assist diagnostics industry executives ... and market shares of major cancer diagnostic product suppliers in major countries by individual test Five-year test volume and sales forecasts ...

February 2016 925 pages

Global Peptide Cancer Vaccine Market & Clinical Pipeline Insight

US$ 1,500.00

... Peptide Cancer Vaccine Need of Peptide Cancer Vaccines Clinical Trials Efficacy Study of Synthetic Peptide Analog Obtained From WT1 Oncoprotein Wide Spectrum Action of Peptide Cancer Vaccines against Major Cancer Global Peptide Cancer Vaccine Pipeline: 41 Vaccines Global Peptide Cancer Vaccine ...

February 2016 142 pages

Epiomic Epidemiology Series: Pancreatic Cancer Forecast in 17 Major Markets 2016-2026

US$ 6,382.00

... Pancreatic Cancer include: • Obesity • Diabetes • Jaundice • Pancreatitis • Gallbladder enlargement This report is built using data and information sourced from the proprietary Epiomic ... to date information from patient registries, clinical trials and epidemiology studies. All of the sources used to generate the ...

January 2016 54 pages

Global Cancer Diagnostics Market Size, Competitive Analysis, Strategies and Forecast Upto 2022

US$ 4,000.00

... . The key members in the cutting edge growth diagnostics market incorporate GE Healthcare, Abbott Laboratories, Allegro Diagnostics Corp., Siemens Healthcare, Agilent Technologies Inc ... Inc., Veridex LLC, Nanosphere Inc., A. Menarini Diagnostics S.r.l., Fujirebio Diagnostics Inc. also, Oncolys BioPharma Inc Cancer Diagnostics Market, by Method: Biopsy Endoscopy Tumor Biomarker Tests ...

January 2016 130 pages

Non-Small Cell Lung Cancer: Update Bulletin [Jan 2016]

US$ 995.00

... that have the potential to shape the targeted treatment of Non-Small Cell Lung Cancer (NSCLC). Topics covered include opinions about Tagrisso (osimertinib; ... Merck’s Keytruda as a second-line treatment for PD-L1 positive advanced NSCLC? Update Bulletins include expert insight and analysis based on FirstWord ...

December 2015

Global Cancer/Tumor Profiling Industry 2015 Market Research Report

US$ 2,850.00

2015 Global Cancer/Tumor Profiling Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Cancer/Tumor Profiling industry, focusing on the main ... with: 1.) basic information; 2.) the Asia Cancer/Tumor Profiling industry; 3.) the North American Cancer/Tumor Profiling industry; 4.) the European Cancer/Tumor Profiling industry; 5.) market entry and investment feasibility ...

December 2015 161 pages

Global Renal Cancer Treatments Drug Industry 2015 Market Research Report

US$ 2,850.00

2015 Global Renal Cancer Treatments Drug Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Renal Cancer Treatments Drug industry, focusing on the ... with: 1.) basic information; 2.) the Asia Renal Cancer Treatments Drug industry; 3.) the North American Renal Cancer Treatments Drug industry; 4.) the European Renal Cancer Treatments Drug industry; 5.) market entry and investment feasibility ...

December 2015 161 pages

Global Cervical Cancer Vaccine Market Opportunities, 2020

US$ 4,000.00

... . “Global Cervical Cancer Vaccine Market Opportunities, 2020” report elaborates following aspects related to global cervical cancer vaccine market: Global Cervical Cancer Vaccine Market Size, Share & Forecast Segmental Analysis – By Region & By Company Policy & Regulatory Landscape Changing Market ...

December 2015 105 pages

Generic Oncology Drug Manufacturing Plant Project Report: Industry Trends, Manufacturing Process, Machinery, Raw Materials, Cost and Revenue

US$ 1,200.00

... setting up a generic oncology drug manufacturing plant? How much income will the generic oncology drug manufacturing plant generate? What will be the profitability of the generic oncology drug manufacturing plant? What will be the NPV of the generic oncology drug manufacturing plant? What ...

December 2015 69 pages

Epiomic Epidemiology Series: Thyroid Cancer Forecast in 17 Major Markets 2015-2025

US$ 6,382.00

... from the proprietary Epiomic patient segmentation database. To ... registries, clinical trials and epidemiology studies. All of the ... Thyroid Cancer’s incident population. Examination of the incidence of the different causative gene mutations for Thyroid Cancer. Identify sub-populations within Thyroid Cancer ...

November 2015 66 pages

Epiomic Epidemiology Series: Testicular Cancer Forecast in 20 Major Markets 2015-2025

US$ 6,382.00

... from the proprietary Epiomic patient segmentation database. To ... patient registries, clinical trials and epidemiology studies. All of the ... Testicular Cancer’s incident population. Examination of various elevated serum levels present in Testicular Cancer patients. Identify sub-populations within Testicular Cancer ...

November 2015 54 pages

Global - Cancer Vaccines Market and Pipeline Vaccines Analysis to 2020

US$ 1,290.00

... Cancer Vaccines Market to 2020 I. Provenge 3. Cancer Vaccines Market - Regional Analysis to 2020 I. United States - Cancer Vaccines Market II. Europe - Cancer Vaccines Market III. Asia - Cancer Vaccines Market 4. Global Cancer Vaccines Market - Major Deals 5. Global Cancer Vaccines - Funding 6. Global Cancer ...

November 2015 213 pages

2016 Global Cancer Diagnostics Market: Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Strategies - France, Germany, Italy, Japan, Spain, UK, US

US$ 27,800.00

... and market segment; profiles leading players and potential market entrants; and identifies specific business opportunities for suppliers. Rationale The cancer diagnostics market is on the ... of the disease. During the next five years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological ...

November 2015 1200 pages

2016 Europe Cancer Diagnostics Market: Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Strategies - France, Germany, Italy, Spain, UK

US$ 15,760.00

... and market segment; profiles leading market players and potential entrants; and suggests alternative business expansion strategies for suppliers. Rationale The cancer diagnostics market ... of the disease. During the next five years, the European cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological ...

November 2015 820 pages

2016 France Cancer Diagnostics Market: Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Strategies

US$ 5,440.00

... opportunities emerging in the cancer diagnostics market during the next five years. The report examines trends in the French cancer diagnostics markets; reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers and market segment ...

November 2015 585 pages

2016 Germany Cancer Diagnostics Market: Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Strategies

US$ 5,440.00

... opportunities emerging in the cancer diagnostics market during the next five years. The report examines trends in the German cancer diagnostics markets; reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers and market segment ...

November 2015 585 pages

2016 Italy Cancer Diagnostics Market: Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Strategies

US$ 5,440.00

... opportunities emerging in the cancer diagnostics market during the next five years. The report examines trends in the Italian cancer diagnostics markets; reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers and market segment ...

November 2015 570 pages

2016 Japan Cancer Diagnostics Market: Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Strategies

US$ 6,080.00

... opportunities emerging in the cancer diagnostics market during the next five years. The report examines trends in the Japanese cancer diagnostics markets; reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers and market segment ...

November 2015 590 pages

2016 Spain Cancer Diagnostics Market: Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Strategies

US$ 5,440.00

... opportunities emerging in the cancer diagnostics market during the next five years. The report examines trends in the Spanish cancer diagnostics markets; reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers and market segment ...

November 2015 565 pages

2016 U.K. Cancer Diagnostics Market: Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Strategies

US$ 5,440.00

... business opportunities emerging in the cancer diagnostics market during the next five years. The report examines trends in the UK cancer diagnostics markets; reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers and market segment ...

November 2015 565 pages

2016 U.S. Cancer Diagnostics Market: Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Strategies

US$ 7,840.00

... business opportunities emerging in the cancer diagnostics market during the next five years. The report examines trends in the US cancer diagnostics markets; reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers and market segment ...

November 2015 620 pages

2016 Global Cancer Diagnostics Market: Emerging Tests, Technology Assessment, Instrumentation Review, Country Volume and Sales Forecasts, Strategic Profiles of Leading Suppliers

US$ 6,000.00

... cancer diagnostics market, including emerging tests, technologies, instrumentation, sales forecasts by country, and strategic profiles of leading suppliers. The report presents: Estimated numbers of cancer ... significance and market needs for both current and emerging cancer diagnostic tests, as well as listings of companies, universities and research centers developing or marketing new ...

November 2015 510 pages

2016 France Cancer Diagnostic Testing Market: Sales and Market Shares of Major Suppliers by Assay

US$ 2,560.00

... unique report from VPGMarketResearch provides France sales and market share estimates for major suppliers of cancer diagnostic testing products by assay and country. The ...

November 2015 100 pages

2016 Germany Cancer Diagnostic Testing Market: Sales and Market Shares of Major Suppliers by Assay

US$ 2,360.00

... unique report from VPGMarketResearch provides Germany sales and market share estimates for major suppliers of cancer diagnostic testing products by assay and country. The ...

November 2015 128 pages

2016 Future Horizons and Growth Strategies in the Italian Hospital Tumor Marker Testing Market: Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities

US$ 3,080.00

This new report from VPGMarketResearch contains 525 pages, 38 tables, and presents a comprehensive analysis of the Italian hospital tumor marker testing market, including: Major issues pertaining to the Italian hospital laboratory practice, as well as key economic, regulatory, demographic, social and ...

November 2015 525 pages

2016 Future Horizons and Growth Strategies in the Japanese Hospital Tumor Marker Testing Market: Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities

US$ 3,880.00

This new report from VPGMarketResearch contains 537 pages, 42 tables, and presents a comprehensive analysis of the Japanese hospital tumor marker testing market, including: Major issues pertaining to the Japanese hospital laboratory practice, as well as key economic, regulatory, demographic, social and ...

November 2015 537 pages

2016 Future Horizons and Growth Strategies in the Spanish Hospital Tumor Marker Testing Market: Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities

US$ 3,080.00

This new report from VPGMarketResearch contains 521 pages, 41 tables, and presents a comprehensive analysis of the Spanish hospital tumor marker testing market, including: Major issues pertaining to the Spanish hospital laboratory practice, as well as key economic, regulatory, demographic, social and ...

November 2015 521 pages

2016 Future Horizons and Growth Strategies in the US Hospital Tumor Marker Testing Market: Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities

US$ 5,200.00

This new report from VPGMarketResearch contains 567 pages, 50 tables, and presents a comprehensive analysis of the US hospital tumor market testing market, including: Major issues pertaining to the US laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with ...

November 2015 567 pages

2016 Future Horizons and Growth Strategies in the UK Hospital Tumor Marker Testing Market: Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities

US$ 3,080.00

This new report from VPGMarketResearch contains 527 pages, 37 tables, and presents a comprehensive analysis of the UK hospital tumor marker testing market, including: Major issues pertaining to the UK hospital laboratory practice, as well as key economic, regulatory, demographic, social and technological ...

November 2015 527 pages

2016 Future Horizons and Growth Strategies in the French Tumor Marker Testing Market: Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities

US$ 5,440.00

Highlights Comprehensive 585-page analysis of the French tumor marker testing market. Major issues pertaining to the French laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years. Mortality statistics ...

November 2015 585 pages

2016 Future Horizons and Growth Strategies in the UK Tumor Marker Testing Market: Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities

US$ 5,440.00

Complete report $5,400. DataPack (test volumes, sales forecasts, supplier shares) $1,950. Highlights Comprehensive 575-page analysis of the UK tumor marker testing market. Major issues pertaining to the UK laboratory practice, as well as key economic, regulatory, demographic, social and technological trends ...

November 2015 575 pages

2016 Future Horizons and Growth Strategies in the Global Tumor Marker Testing Market: Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities

US$ 27,800.00

... segmentation analysis, including reviewof the market dynamics, structure, size, growth and major suppliersby country. Cancer statistics, etiology and recent ... current and emerging tumor markers, including: Biochemical Markers Oncogenes Growth Factors Hormones Colony Stimulating Factors Lymphokines Immunohistochemical Stains, and ...

November 2015 1200 pages

Filters

Search

Publishers

4
3
1
14
2
2
26
10
1
3
1
1
6
9
10
2
4
10
20
5
97
8
3
100
7
1
8
3
1
1
6
12
2
1
11
18
8
1
4
12
1
5
4
11
43
7
2
1,108
5
25
2
73
17
10
22
12
5
1
10
17
2
30
4
9

Regions

26
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
4
11
5
5
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
27
7
7
7
7
7
7
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
5
5
5
5
19
21
8
7
71
55
54
54
53
52
53
102
839

Price

Date

Pages

Offers

14
3
4
1